HS content, reduced anticoagulant properties of HS, and increased PAI-1 secretion disorganized the endothelial matrix, and promoted fibrin formation and vascular damage. This points to DD as an important factor in the development of vascular disorders.
Fibrin split product D-dimer (DD) is thought to be involved in the development of vascular disorders, and its level increases gradually with increasing severity of peripheral vascular sclerosis (van der Bom et al., 2001 ). The mechanism of a possible DD effect remains unclear, although this soluble fibrin-derived molecule is known to exert distinct biological effects in various cell types, including the endothelium. It alters cell adhesion and spreading, modifies the cytoskeleton and influences the system of plasminogen activation (Herrick et al., 1999) . It is believed that such phenotypic alterations are accompanied by changes in the properties and accumulation of the glycosaminoglycan (GAG) component of extracellular matrix (ECM). However, the effect of DD on endothelial GAGs has not been studied.
Heparan sulphate (HS) is of particular importance because endothelial cells produce the anticoagulant HS, which directly modulates the coagulation/fibrinolysis balance by binding to antithrombin (AT). It was demonstrated that this binding is regulated by endogenous NO production (Irokawa et al., 1997) , which, in turn, is down-regulated by fibrin degradation products, including DD (Freedman et al., 1995) . Therefore, it was of interest to study the effect of DD on the accumulation and properties of endothelial pericellular HS, monitoring simultaneously the level of NO. On the other hand, it seemed important to estimate the secretion of plasminogen activator inhibitor-1 (PAI-1), which is the main regulator of the plasminogen activation system and also reflects the general degradation potential of endothelial matrix (Menashi et al., 1993) .
In the present study we have demonstrated that DD reduced the accumulation of endothelial pericellular HS and affected its properties, including the ability to bind to antithrombin.
It is suggested that the decrease of NO level is responsible for HS impairment. In contrast, the DD-induced stimulation of PAI-1 secretion was not mediated by endogenous NO. These properties of DD indicate that it is an active and important component in the development of vascular disorders.
MATERIALS AND METHODS
Cell culture medium DMEM/F12 and fetal calf serum (FCS) were purchased from Gibco. The necessary additives for culturing, including endothelial cell growth factor (ECGF), trypsin-EDTA solution for endothelial cells, and phenol red-free M199 medium were from Sigma. Trypsin, soybean trypsin inhibitor, chondroitinase ABC and AC, heparinase I, orgelase, cetylpiridinium chloride, antithrombin (III)-agarose, 2,2¢-azinobis-3-ethylbenzthazoline-6-sulphonic acid, L-arginine, L-ascorbic acid, bradykinin, N w -methyl-L-arginine, plasminogen, tissue plasminogen activator, thrombin, and aprotinin were also purchased from Sigma. Sephadex G-50 and G-25 were from Pharmacia. dishes in DMEM/F12 medium, supplemented with 15% FCS, 0.5% ECGF, 90 mg/ml heparin, 2 mM glutamine, 50 U/ml penicillin, 50 mg/ml streptomycin and 1 mg/ml amphotericin B. Experimental procedure. All experiments were performed with the 4th or 5th passages of culture. Endothelial cells were allowed to reach confluence (4.5-5.5´10 4 cells/cm 2 ) and were then transferred for 24 h to the heparin-free (Miller et al., 1998) , serum-rich (25% FCS) (Crook et al., 2000) , phenol red-free medium M199 (L-arginine concentration was adjusted to that in DMEM/F12). Cells were then extensively washed and exposed to DD (0-3.0 mM), in the serum-deprived M199 medium, with 7.0 mCi/ml (Huang et al., 2000) with or without 1.5 mM DD. Some cells were also stimulated by treatment with 0.5 mM bradykinin for 1 h. Cell viability was > 95%, as determined by the trypan blue exclusion test. Cell monolayers were used for the preparation of the cell-associated GAGs concentrations of PAI-1 and nitrite were determined in the conditioned medium.
Methods. The purity of human D-dimer (Marder et al., 1976) was checked by electrophoresis.
The preparation and identification of pericellular GAGs was performed, as described previously (Yevdokimova & Yefimov, 2001 (Shivley & Conrad, 1976) .
The reaction was stopped by saturation with NaHCO 3 . One ml of the mixture (> 15´10 4 d.p.m.) was loaded onto Sephadex G-25 (fine) column (0.95´100 cm) and eluted with 0.5 M NH 4 HCO 3 at 4 ml/h. One ml fractions were analyzed for the radioactivity.
In the second case 14 C-HS was cleaved at pH 3.9 by 0.24 M NaNO 2 in 1.8 M CH 3 COOH for 2 h at 20 o C (Lindahl et al., 1973) . At pH 3.9 HNO 2 cleaves HS at unsubstituted glucosamine residues (GlcNH 2 ), and the reaction products were analyzed by exclusion Sephadex G-50 (fine) chromatography. One ml samples were loaded onto 10 ml columns and eluted with 0.1 M Na-acetate buffer, pH 5.0. The radioactivity of the high mass molecular fraction was subtracted from the radioactivity of the total sample and expressed in percent of the latter. Binding of 14 C-HS to antithrombin (AT)-agarose was determined according to (Mertens et al., 1992) with some modifications. AT-agarose beads were swollen in 0.01 M Tris/HCl, 0.05 M NaCl, 0.01 M MgCl 2 , pH 7.4, overnight at 10 o C. 14 C-HS sample (> 3.5´10 4 d.p.m.)
was incubated with AT-agarose in the same buffer, supplemented with 0.01% Triton X-100 and 25 mg/ml exogenous heparin for 4 h at 20 o C with constant shaking. The beads were washed by incubation (for 30 min) and centrifugation (500 g, 5 min) successively in
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Determination of PAI-1 in endothelial conditioned medium was carried out by ELISA. The optimal dilution of goat antibodies for PAI-1 detection was found to be 1:400, and the dilution of swine peroxidase-conjugated secondary antibody was 1:800. The reaction was detected with 2,2¢-azinobis-3-ethylbenzthazoline-6-sulphonic acid at 405 nm. NO production was determined by measuring the nitrite concentration in the conditioned medium without protease inhibitors by the Greiss reaction (Green et al., 1982) .
Statistical analysis. Results were compared using unpaired t-test. P values of < 0.05 were regarded as significant. (Fig. 1) . The incorporation of both precursors into hyaluronic acid (HA) was less than 20% of total radioactivity. These results are consistent with the data on synthesis of mainly sulphated GAGs by endothelial cells of various origin (Kennedy et al., 1986; Amanuma & Mitsui, 1991) . DD administration (Fig. 2, GAGs fractions obtained by DEAE-cellulose chromatography (cf. Fig. 1 ) confirmed that DD affected exclusively HS, while incorporation into HA, CS and DS remained unaltered (Fig. 3) . The changes of pericellular HS structure under DD treatment were investigated on the basis of the degradation of 14 C-HS by HNO 2 at pH 1.5 and pH 3.9. Since HNO 2 at pH 1.5 specifically cleaves HS at N-sulpho-D-glucosamine residues (GlcNSO 3 ), leaving N-acetyl-D-glucosamine residues (GlcNAc) unaltered, it is possible to evaluate the degree of N-sulphation. Disaccharides are released from the regions of the polymer chain with contiguous N-sulphated disaccharide units, whereas tetrasaccharides (and higher oligosaccharides) are obtained from the regions with GlcNAc residues. The results of Sephadex G-25 fractionation of the HS cleavage products showed that the radioactivity was redistributed from peak I to peaks II and III in the cells treated with 1.5 mM DD (Fig. 4) . For statistical processing the fractions of peaks I (No. 32-40), , and III (No. 53-56) from each sample were combined and expressed in percent of total 14 C-HS (Table 1). The differences are significant and proved the increased degree of N-sulphation upon DD treatment. At pH 3.9 HNO 2 cleaves HS at unsubstituted glucosamine residues (GlcNH 2 ). As can be seen from Fig. 5 the level of N-unsubstitution of HS is increased in the DD-treated endothelial cells, as compared to control cells.
RESULTS

Incorporation
Moreover, the DD effect on HS structure involves its binding to AT-agarose. DD decreased the basal level of nitrite in the conditioned medium, but bradykinin stimulated NO production by the control and DD-treated cells to the same extent (about 1.6-fold, not shown), indicating the preserved response of endothelial NO synthase (eNOS) upon DD treatment. [ 14 C]GAGs were separated as described in Materials and Methods. Data are expressed as mean ± S.E. of 3 independent experiments in triplicate. ****Significant at P < 0.001.
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L-NMMA, a known competitive inhibitor of NO synthesis, suppressed nitrite formation to the level, comparable to the effect of 1.5 mM DD, decreasing at the same time the incorporation of [ 14 C]acetate into HS (Table 2) without affecting incorporation of the label into HA, CS and DS (not shown). Moreover, the L-NMMA-treated cells produced HS with an increased degree of N-sulphation (Tables 1  and 2 ) and N-unsubstitution (Table 2) , and with a decreased ability to bind to AT-agarose (Table 2) . It is known that L-ascorbic acid enhances NO production, without influencing the expression of eNOS (Huang et al., 2000) . The endothelial cells, which were exposed simultaneously to DD and L-ascorbic acid, produced more NO (Table 2) , and accumulated more 14 C-HS in pericellular matrix (Table 2) (Fig. 5, Table 2 ), increased HS-AT binding (Fig. 5, Table 2 ) and almost normalized the level of N-sulphation (Tables 1 and 2).
For comparison purposes we have demonstrated the up-regulation of PAI-1 secretion by DD (Fig. 5) . In contrast to the normalizing effect of L-ascorbic acid on HS level and its properties in the DD-treated cells, PAI-1 secretion remained unchanged. Endothelial cells did not respond either to L-NMMA or to L-ascorbic acid in terms of PAI-1 secretion.
DISCUSSION
DD is a product of the cross-linked fibrin degradation by the fibrinolytic system. The elevated plasma DD seems to be a marker of a systemic prothrombotic state, and application of anticoagulant therapy can normalize its level. It has been proposed that DD may predict vascular complications, particularly in cases, when its high level is associated with an elevated level of prothrombin fragment 1+2 versus the normal level of the thrombin-AT complexes. Such alterations are observed in systemic sclerosis (Ames et al., 1997) , antiphospholipid syndrome (Ames et al., 1996) , and diabetes mellitus (Gruden et al., 1993) , i.e., disorders with evident micro-and macrovascular pathology. These phenomena Confluent endothelial cells were exposed to 1.5 mM of DD, 30 mM N-methyl-L-arginine (L-NMMA), 50 mM L-ascorbic acid (Asc) and 1.5 mM of DD + 50 mM L-ascorbic acid. Concentration of PAI-1 in the conditioned medium was determined by ELISA, as described in Materials and Methods. Data are expressed as means ± S.E. of 2 independent experiments in triplicate. ****Significant at P < 0.001, ***significant at P < 0.01, as compared to control. The preparation of 14 C-HS samples and chromatography was as described in Materials and Methods.
are interpreted as due to the impaired function of the anticoagulant HS-AT system, possibly as a result of anti-endothelial cell antibodies, which may hinder AT-HS binding, or, in the case of diabetes, additionally due to the down-regulation of HS by a high glucose level (van Det et al., 1996) . The effects of DD in vitro (Herrick et al., 1999) allow to assume its direct participation in the development of vascular disorders.
In this study we have demonstrated that DD decreased the content of HS in pericellular matrix of endothelial cells, and impaired the structure and the anticoagulant properties of HS. We propose the following explanation of the observed phenomena.
It is known that various metabolic products may directly affect the accumulation and structure of HS chains during their initial formation or recycling (Prydz & Dalen, 2000) . According to our data, DD inhibits NO production by endothelial cells which is in line with the down-regulation of eNOS mRNA expression (Freedman et al., 1995) . The reduction of NO concentration was shown to have two direct effects on the level and properties of pericellular HS. On the one hand, a low NO level inhibits the physiological desaminative cleavage of HS at unsubstituted GlcNH 2 (Vilar et al., 1997; Ding et al., 2001) which is manifested by the increased content of HS with N-unsubstituted chains. On the other Vol. 50 D-dimer impairs the properties of heparan sulphate 285 Tetra-II 22.6 ± 1.9 28.2 ± 1.8* 29.9 ± 2.6* 25.9 ± 2.5 Higher I 57.2 ± 5.6 44.9 ± 2.3*** 43.1 ± 3.9** 51.0 ± 4.8* HS was isolated from the pericellular matrix of endothelial cells treated with 1.5 mM DD, 30 mM L-NMMA and 1.5 mM DD + 50 mM L-ascorbic acid (Asc). It was cleaved by HNO 2 at pH 1.5. The fragments obtained were separated by Sephadex G-25 chromatography. Data represent the % of the radioactivity of total 14 C-HS for each sample, and are expressed as means ± S.E. of 2 independent experiments in triplicate. Experiments with L-ascorbic acid were done in duplicate. ***Significant at P < 0.01, ** significant at P < 0.02, *significant at P < 0.05, as compared to control. (Kurose et al., 1995; Irokawa et al., 1997) , and induces the release of reactive oxygen species (ROS) into the extracellular compartment (Niu et al., 1996) . ROS depolymerize HS in vitro (Moseley et al., 1995) and in vivo (Okasora et al., 1992) at the low-sulphated regions of the molecule, without affecting the high-sulphated regions. Therefore, the total amount of pericellular HS decreases, but the amount of sulphate groups increases. The data given in Table 2 show that the DD influence on the accumulation and properties of pericellular HS and NO production correspond to the above mentioned effects of the reduction of NO level. Moreover, we have demonstrated that DD reduced the anticoagulant fraction of HS. It is known that anticoagulant HS contains a pentasaccharide sequence, which is responsible for specific HS binding to AT. The increased N-sulphation of this sequence was shown to inhibit AT-anticoagulant HS binding (Kovensky et al., 1990; Gallagher, 1997) . Thus the increase of N-sulphation and simultaneous decrease of AT binding under DD treatment are consistent with these data.
It can also be seen from Table 2 that the L-NMMA-induced inhibition of NO production associated with the decreased accumulation of pericellular HS and deterioration of its properties resembles the effect of 1.5 mM DD. And, at last, the addition of L-ascorbic acid to the DD-treated cells enhancing the activity of eNOS, to abolished the reduction of nitrite concentration, recovers the [ 14 C]acetate incorporation into HS, decreasing its N-unsubstitution and N-sulphation and improving HS binding to AT. We suppose, therefore, that the inhibition of NO production by DD promotes the development of oxidative stress and generation of ROS, which, in turn, destroy the low-sulphated regions of HS chains, inhibit HS accumulation in pericellular matrix and diminish its anticoagulant properties.
Another possible mechanism, which may mediate the effect of the DD-induced inhibition of nitrite production on HS level may involve activation of the transcription nuclear factor (NF)-kB signalling by ROS (True et al., 2000) and, hence, heparanase activation (Andela et al., 2000) . Heparanase is known to degrade HS at various sites but particularly cleaves its AT binding pentasaccharide (Vlodavsky & Friedman, 2001) . This leads to the decreased accumulation of HS and decreased AT-HS binding, which we observed on DD administration.
The g117-133 sequence is exposed in DD, and its specific binding to intercellular adhesion molecule-1 (ICAM-1) (Harley & Powell, 1999) determines the interaction of DD with endothelial cells. ICAM-1 is down-regulated in endothelial cells cultured in their basic medium M 199 (Miller et al., 1998; Crook et al., 2000) . The cells must be activated in the serum-rich, heparin-free medium to reveal a significant response to DD in terms of NO production and HS accumulation. DD stimulates the secretion of PAI-1, but this effect is hardly connected to the inhibition of endogenous NO production, because neither L-NMMA nor L-ascorbic acid have any effect on basal or DD-stimulated PAI-1 secretion. Our data, therefore, confirm the lack of response of basal PAI-1 secretion in endothelial cells to the increased level of endogenous NO (Swiatkowska et al., 2000) . Besides, we could detect the effect of DD on PAI-1 secretion irrespective of cell activation (not shown). This casts doubts on the participation of ICAM-1 in cell response to DD in terms of PAI-1 secretion, and corresponds to the results of Olman et al. (1999) , who showed that in fibroblasts DD induces transcription of PAI-1 through the definite, highly conserved, region of PAI-1 gene promoter. These authors suppose that DD possesses conformationally dependent signaling epitopes that regulate PAI-1 expression, which may be exposed upon plasmin cleavage of a cross-linked fibrin in a manner similar to that seen with thrombin 286 N.Yu. Yevdokimova and others 2003 cleavage of fibrinogen. Potential DD epitopes have yet to be characterized. Thus, on the one hand, the DD-induced stimulation of PAI-1 secretion inhibits plasminogen activation, and, hence, may have a compensatory action, decreasing HS shedding (Bernfield, 1999) and blocking fibrinolysis and DD formation. However, at the same time an inactive plasmin decreases the activity of specific matrix metalloproteinases (Menashi et al., 1993) and promotes fibrin deposition, which is known to have profibrotic properties (Senior et al., 1986) . On the other hand, and, very likely due to another mechanism, DD inhibits the binding of anticoagulant HS to AT, leading to inadequate thrombin neutralization and excessive fibrin formation. Thrombin, like fibrin, not only possesses profibrotic properties (Dawes et al., 1993) , but, like plasmin, can catalyse HS shedding (Bernfield, 1999) . Moreover, if fibrin degradation does occur (because of reasons apart from DD inhibition of PAI-1 production), it causes an increase in DD production, forming a vicious circle. Thus, taking into the account the above aspects of DD action it facilitates formation of fibrin and thrombin, which damage endothelial cells, attracts fibroblasts and stimulates their proliferation. The loss of HS of endothelial ECM disturbs the metabolic action of various growth factors and alters the permeability of the endothelial monolayer to large molecules. All the above events take place during decreased NO production, which not only prevents vasodilation, but down-regulates the expression of integrin anb3, facilitating endothelial cell survival (Murohara et al., 1998) . Hence, all consequences of DD influence on endothelial cells, either directly or via the coagulation/fibrinolysis system, contribute to the development of vascular malfunction.
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